NCT04060173 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 Status COMPLETED Phase PHASE1
NCT04052932 A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout Status COMPLETED Phase PHASE3
NCT04047394 A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult Volunteers Status UNKNOWN Phase PHASE1
NCT04040907 The the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XNW3009 in Health Subject Status COMPLETED Phase PHASE1
NCT04040816 Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients Status COMPLETED Phase PHASE2
NCT04031469 A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease Status SUSPENDED Phase N/A
NCT03994731 Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout Status COMPLETED Phase PHASE4
NCT03934099 A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia Status COMPLETED Phase PHASE2
NCT03927677 The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults. Status COMPLETED Phase PHASE1
NCT03906006 A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03847753 Exploring the Comorbidity Between Mental Disorders and General Medical Conditions Status COMPLETED Phase N/A
NCT03635957 Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout Status COMPLETED Phase PHASE4
NCT03601260 The Percentage of Cases of Acute Treatment With Allopurinol in Gout Patients Status UNKNOWN Phase NA